SETD3 and colorectal cancer: We utilized the R2 Genomics Analysis and Visualization Platform clinical data (http://r2.amc.nl) derived from whole-genome expression of the survival rate of colorectal cancer patients with high and low expression of SETD3 (Fig. 1a).